BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND IL2, IL-2, 3558, ENSG00000109471, P60568 AND Diagnosis
30 results:

  • 1. cancer-related fatigue: Towards a more targeted approach based on classification by biomarkers and psychological factors.
    Schmidt ME; Maurer T; Behrens S; Seibold P; Obi N; Chang-Claude J; Steindorf K
    Int J Cancer; 2024 Mar; 154(6):1011-1018. PubMed ID: 37950650
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Circulating cytokines as predictors of depression in patients with breast cancer.
    Ho HY; Chin-Hung Chen V; Tzang BS; Hsieh CC; Wang WK; Weng YP; Hsu YT; Hsaio HP; Weng JC; Chen YL
    J Psychiatr Res; 2021 Apr; 136():306-311. PubMed ID: 33636686
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Study of correlation between biochemical indicators and radiological diagnostic parameters of breast cancer.
    Orujova IN; Azizova GI; Gafarov IA; Orujov AH
    Klin Lab Diagn; 2020 Dec; 65(12):738-743. PubMed ID: 33373504
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Lifestyle among long-term survivors of cancers in young adulthood.
    Bøhn SH; Lie HC; Reinertsen KV; Fosså SD; Haugnes HS; Kiserud CE; Loge JH; Wisløff T; Thorsen L
    Support Care Cancer; 2021 Jan; 29(1):289-300. PubMed ID: 32358776
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Treatment of Metastatic or High-Risk Solid cancer Patients by Targeting the Immune System and/or Tumor Burden: Six Cases Reports.
    Nicolini A; Ferrari P; Morganti R; Carpi A
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795079
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Inequality in breast cancer care in a Brazilian capital city: a comparative analysis of narratives.
    Cabral ALLV; Giatti L; Martínez-Hernáez Á; Cherchiglia ML
    Int J Equity Health; 2019 Jun; 18(1):88. PubMed ID: 31196095
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Employment Status and Work Ability in Long-Term Young Adult cancer Survivors.
    Dahl AA; Fosså SD; Lie HC; Loge JH; Reinertsen KV; Ruud E; Kiserud CE
    J Adolesc Young Adult Oncol; 2019 Jun; 8(3):304-311. PubMed ID: 30900929
    [No Abstract]    [Full Text] [Related]  

  • 8. A mechanistic cohort study evaluating cognitive impairment in women treated for breast cancer.
    Vardy JL; Stouten-Kemperman MM; Pond G; Booth CM; Rourke SB; Dhillon HM; Dodd A; Crawley A; Tannock IF
    Brain Imaging Behav; 2019 Feb; 13(1):15-26. PubMed ID: 28466438
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. 2003-2013, a valuable study: Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in stage IV breast cancer.
    Lin M; Liang S; Jiang F; Xu J; Zhu W; Qian W; Hu Y; Zhou Z; Chen J; Niu L; Xu K; Lv Y
    Immunol Lett; 2017 Mar; 183():37-43. PubMed ID: 28143792
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Influence of Circulating Tumour Cells on Production of IL-1α, IL-1β and IL-12 in Sera of Patients with Primary diagnosis of breast cancer Before Treatment.
    Vilsmaier T; Rack B; König A; Friese K; Janni W; Jeschke U; Weissenbacher T;
    Anticancer Res; 2016 Oct; 36(10):5227-5236. PubMed ID: 27798883
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Improved Natural Killer cell activity and retained anti-tumor CD8(+) T cell responses contribute to the induction of a pathological complete response in HER2-positive breast cancer patients undergoing neoadjuvant chemotherapy.
    Muraro E; Comaro E; Talamini R; Turchet E; Miolo G; Scalone S; Militello L; Lombardi D; Spazzapan S; Perin T; Massarut S; Crivellari D; Dolcetti R; Martorelli D
    J Transl Med; 2015 Jun; 13():204. PubMed ID: 26116238
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A different immunologic profile characterizes patients with HER-2-overexpressing and HER-2-negative locally advanced breast cancer: implications for immune-based therapies.
    Muraro E; Martorelli D; Turchet E; Miolo G; Scalone S; Comaro E; Talamini R; Mastorci K; Lombardi D; Perin T; Carbone A; Veronesi A; Crivellari D; Dolcetti R
    Breast Cancer Res; 2011; 13(6):R117. PubMed ID: 22112244
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Anesthetic technique and the cytokine and matrix metalloproteinase response to primary breast cancer surgery.
    Deegan CA; Murray D; Doran P; Moriarty DC; Sessler DI; Mascha E; Kavanagh BP; Buggy DJ
    Reg Anesth Pain Med; 2010; 35(6):490-5. PubMed ID: 20975461
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Polymorphisms in cytokine genes and serum cytokine levels among New Mexican women with and without breast cancer.
    Erdei E; Kang H; Meisner A; White K; Pickett G; Baca C; Royce M; Berwick M
    Cytokine; 2010 Jul; 51(1):18-24. PubMed ID: 20418110
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. High immunogenic potential of p53 mRNA-transfected dendritic cells in patients with primary breast cancer.
    Met O; Balslev E; Flyger H; Svane IM
    Breast Cancer Res Treat; 2011 Jan; 125(2):395-406. PubMed ID: 20336365
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Cytokines in the management of high risk or advanced breast cancer: an update and expectation.
    Carpi A; Nicolini A; Antonelli A; Ferrari P; Rossi G
    Curr Cancer Drug Targets; 2009 Dec; 9(8):888-903. PubMed ID: 20025599
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Cognitive behavioral stress management effects on psychosocial and physiological adaptation in women undergoing treatment for breast cancer.
    Antoni MH; Lechner S; Diaz A; Vargas S; Holley H; Phillips K; McGregor B; Carver CS; Blomberg B
    Brain Behav Immun; 2009 Jul; 23(5):580-91. PubMed ID: 18835434
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Immune responses to guided imagery during breast cancer treatment.
    Lengacher CA; Bennett MP; Gonzalez L; Gilvary D; Cox CE; Cantor A; Jacobsen PB; Yang C; Djeu J
    Biol Res Nurs; 2008 Jan; 9(3):205-14. PubMed ID: 18077773
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Oestrogen receptor negative breast cancers exhibit high cytokine content.
    Chavey C; Bibeau F; Gourgou-Bourgade S; Burlinchon S; Boissière F; Laune D; Roques S; Lazennec G
    Breast Cancer Res; 2007; 9(1):R15. PubMed ID: 17261184
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Tumor cell expression of HLA-DM associates with a Th1 profile and predicts improved survival in breast carcinoma patients.
    Oldford SA; Robb JD; Codner D; Gadag V; Watson PH; Drover S
    Int Immunol; 2006 Nov; 18(11):1591-602. PubMed ID: 16987935
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.